The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyperreflexia associated with inflammation of the rat urinary bladder

Neuroscience Letters

Volumn 253, Issue 2, 1998, Pages 123-126

  Jaggar, S I ^a   Sellaturay, S ^a   Rice, A S C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Autacoid local inflammation antagonism; Cystitis; Hyperalgesia; Nerve growth factor; Pain; Visceral

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR AGONIST; PALMIDROL; TURPENTINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYSTITIS; DOSE RESPONSE; FEMALE; HYPERREFLEXIA; INTRAARTERIAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; VISCERAL PAIN;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; FEMALE; INFLAMMATION; INJECTIONS, INTRA-ARTERIAL; LIGANDS; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REFLEX, ABNORMAL; URINARY BLADDER;

EID: 0032483488     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00621-1     Document Type: Article

References (20)

1. Abood M.E., Martin B.R. Molecular neurobiology of the cannabinoid receptor. Int. Rev. Neurobiol. 39:1996;197-221.
2. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 227:1998;1094-1097.
3. Dmitrieva N., McMahon S.B. Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain. 66:1996;87-97.
4. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA. 92:1995;3376-3380.
5. Friedel R.H., Schnurch H., Stubbusch J., Barde Y. Identification of genes differentially expressed by nerve growth factor- and neurotrophin-3-dependent sensory neurons. Proc. Natl. Acad. Sci. USA. 94:1997;12670-12675.
6. Galiègue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
7. Glass M., Dragunow M., Faull R.L.M. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 77:1997;299-318.
8. Herzberg U., Eliav E., Bennett G.J., Kopin I.J. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett. 221:1997;157-160.
9. 2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia. Pain. 75:1998;169-176.
10. Jaggar S.I., Hasnie F.S., Sellaturay S., Rice A.S.C. The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain. 76:1998;189-199.
11. Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19:1996;514-520.
12. Mazzari S., Canella R., Petrelli L., Marcolongo G., Leon A. N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol. 300:1996;227-236.
13. McMahon S.B., Abel C. A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals. Pain. 28:1987;109-127.
14. Natarajan V., Reddy P.V., Schmid P.C., Schmid H.H.O. N-Acylation of ethanolaminephospholipids in canine myocardium. Biochim. Biophys. Acta. 712:1982;342-355.
15. 1 receptors in mouse urinary bladder. Br. J. Pharmacol. 18:1996;2053-2058.
16. Randall M.D., Kendall D.A. Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol. Sci. 19:1998;55-58.
17. 1 receptors. Pain. 75:1998;111-119.
18. Rueff A., Dawson A.J.L.R., Mendell L.M. Characteristics of nerve growth factor induced hyperalgesia in adult rats: dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain. 66:1996;359-372.
19. Skaper S.D., Facci L., Romanello S., Leon A. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J. Neurochem. 66:1996;1157-1166.
20. Stein E.A., Fuller S.A., Edgemond W.S., Campbell W.B. Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br. J. Pharmacol. 119:1996;107-114.